{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T19:08:50Z","timestamp":1762024130778,"version":"build-2065373602"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.intimp.2020.106617","type":"journal-article","created":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T11:54:15Z","timestamp":1590407655000},"page":"106617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Heterologous expression of Intimin and IpaB fusion protein in Lactococcus lactis and its mucosal delivery elicit protection against pathogenicity of Escherichia coli O157 and Shigella flexneri in a murine model"],"prefix":"10.1016","volume":"85","author":[{"given":"Sreerohini","family":"Sagi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balakrishna","family":"Konduru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manmohan","family":"Parida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2020.106617_b0005","first-page":"29","article-title":"The global problem of childhood diarrhoeal diseases: emerging strategies in prevention and management","volume":"5","author":"Mokomane","year":"2018","journal-title":"Ther. Adv. Infect Dis."},{"issue":"1","key":"10.1016\/j.intimp.2020.106617_b0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jinf.2009.05.008","article-title":"A global study of pathogens and host risk factors associated with infectious gastrointestinal disease in returned international travellers","volume":"59","author":"Swaminathan","year":"2009","journal-title":"J. Infect."},{"issue":"9","key":"10.1016\/j.intimp.2020.106617_b0015","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1473-3099(17)30276-1","article-title":"Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015","volume":"17","author":"Troeger","year":"2017","journal-title":"Lancet Infect. Dis."},{"issue":"6","key":"10.1016\/j.intimp.2020.106617_b0020","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMe1315836","article-title":"Rotavirus vaccines\u2014balancing intussusception risks and health benefits","volume":"370","author":"Glass","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"46","key":"10.1016\/j.intimp.2020.106617_b0025","doi-asserted-by":"crossref","first-page":"8285","DOI":"10.1016\/j.vaccine.2011.08.108","article-title":"Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age","volume":"29","author":"Saha","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.intimp.2020.106617_b0030","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/fpd.2013.1704","article-title":"Global incidence of human Shiga toxin\u2013producing Escherichia coli infections and deaths: a systematic review and knowledge synthesis","volume":"11","author":"Majowicz","year":"2014","journal-title":"Foodborne Pathog Dis."},{"issue":"5","key":"10.1016\/j.intimp.2020.106617_b0035","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/QCO.0000000000000475","article-title":"Recent insights into Shigella: a major contributor to the global diarrhoeal disease burden","volume":"31","author":"Baker","year":"2018","journal-title":"CurrOpin Infect Dis."},{"issue":"26","key":"10.1016\/j.intimp.2020.106617_b0040","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJM200006293422601","article-title":"The risk of the hemolytic\u2013uremic syndrome after antibiotic treatment of Escherichia coli O157: H7 infections","volume":"342","author":"Wong","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.intimp.2020.106617_b0045","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jiph.2017.09.025","article-title":"Emergence of antibiotic resistant Shigella species: A matter of concern","volume":"11","author":"Puzari","year":"2018","journal-title":"J. Infect Public Health."},{"issue":"6\u20137","key":"10.1016\/j.intimp.2020.106617_b0050","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ijmm.2005.06.009","article-title":"Enterohaemorrhagic Escherichia coli in human medicine","volume":"295","author":"Karch","year":"2005","journal-title":"Int. J. Med. Microbiol."},{"issue":"8","key":"10.1016\/j.intimp.2020.106617_b0055","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.tim.2009.06.001","article-title":"Controlling injection: regulation of type III secretion in enterohaemorrhagic Escherichia coli","volume":"17","author":"Tree","year":"2009","journal-title":"Trends Microbiol."},{"issue":"25","key":"10.1016\/j.intimp.2020.106617_b0060","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1016\/j.vaccine.2016.04.056","article-title":"The intranasal vaccination of pregnant dams with Intimin and EspB confers protection in neonatal mice from Escherichia coli (EHEC) O157: H7 infection","volume":"34","author":"Rabinovitz","year":"2016","journal-title":"Vaccine."},{"issue":"23","key":"10.1016\/j.intimp.2020.106617_b0065","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1016\/j.vaccine.2011.03.079","article-title":"Reducedfaecal shedding of Escherichia coli O157: H7 in cattle following systemic vaccination with \u03b3-intimin C280 and EspB proteins","volume":"29","author":"Vilte","year":"2011","journal-title":"Vaccine."},{"issue":"5","key":"10.1016\/j.intimp.2020.106617_b0070","first-page":"454","article-title":"Shigellosis: challenges & management issues","volume":"120","author":"Sur","year":"2004","journal-title":"Indian J. Med. Res."},{"issue":"3","key":"10.1016\/j.intimp.2020.106617_b0075","doi-asserted-by":"crossref","first-page":"G319","DOI":"10.1152\/ajpgi.2001.280.3.G319","article-title":"Shigellosis: from symptoms to molecular pathogenesis","volume":"280","author":"Sansonetti","year":"2001","journal-title":"Am. J. PhysiolGastrointest Liver Physiol."},{"issue":"1","key":"10.1016\/j.intimp.2020.106617_b0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/iai.53.1.57-63.1986","article-title":"Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp","volume":"53","author":"Oaks","year":"1986","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.intimp.2020.106617_b0085","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1128\/IAI.06174-11","article-title":"Broadly protective Shigella vaccine based on type III secretion apparatus proteins","volume":"80","author":"Martinez-Becerra","year":"2012","journal-title":"Infect. Immun."},{"issue":"12","key":"10.1016\/j.intimp.2020.106617_b0090","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1128\/IAI.00470-10","article-title":"Domains of the Shigella flexneri type III secretion system IpaB protein involved in secretion regulation","volume":"78","author":"Shen","year":"2010","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.intimp.2020.106617_b0095","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/cmi.2014.86","article-title":"Co-administration of rIpaB domain of Shigella with rGroEL of STyphi enhances the immune responses and protective efficacy against Shigella infection","volume":"12","author":"Chitradevi","year":"2015","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.intimp.2020.106617_b0100","first-page":"6","article-title":"Benefits of combination vaccines: effective vaccination on a simplified schedule","volume":"9","author":"Dodd","year":"2003","journal-title":"Am. J. Manag. Care."},{"issue":"6","key":"10.1016\/j.intimp.2020.106617_b0105","first-page":"1434","article-title":"Combination vaccines against diarrheal diseases","volume":"11","author":"Venkatesan","year":"2015","journal-title":"Hum VaccinImmunother."},{"issue":"31","key":"10.1016\/j.intimp.2020.106617_b0110","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1016\/j.vaccine.2014.04.044","article-title":"Similar immunogenicity of measles\u2013mumps\u2013rubella (MMR) vaccine administrated at 8 months versus 12 months age in children","volume":"32","author":"He","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.intimp.2020.106617_b0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.7774\/cevr.2017.6.1.15","article-title":"The development of mucosal vaccines for both mucosal and systemic immune induction and the roles played by adjuvants","volume":"6","author":"Kim","year":"2017","journal-title":"Clinical Experimen. Vacc. Res."},{"issue":"4","key":"10.1016\/j.intimp.2020.106617_b0120","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4161\/hv.5.4.7553","article-title":"Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins","volume":"5","author":"Berm\u00fadez-Humar\u00e1n","year":"2009","journal-title":"Hum Vaccine."},{"key":"10.1016\/j.intimp.2020.106617_b0125","doi-asserted-by":"crossref","unstructured":"G.F. Asensi, N.F. de Sales, F.F. Dutra, D.F. Feij\u00f3, M.T. Bozza, R.G. Ulrich, A. Miyoshi, K. De Morais, V.A. de Carvalho Azevedo, J.T. Silva, Y. Le Loir, Oral immunization with Lactococcus lactis secreting attenuated recombinant staphylococcal enterotoxin B induces a protective immune response in a murine model. Microb Cell Fact. 12 (1) (2013) 32. http:\/\/www.microbialcellfactories.com\/content\/12\/1\/32.","DOI":"10.1186\/1475-2859-12-32"},{"issue":"31","key":"10.1016\/j.intimp.2020.106617_b0130","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1016\/j.vaccine.2014.05.054","article-title":"Oral immunization with Lactococcus lactis-expressing EspB induces protective immune responses against Escherichia coli O157: H7 in a murine model of colonization","volume":"32","author":"Ahmed","year":"2014","journal-title":"Vaccine."},{"issue":"2","key":"10.1016\/j.intimp.2020.106617_b0135","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2672.2012.05333.x","article-title":"Generation and characterization of an inter-generic bivalent alpha domain fusion protein \u03b1CS from Clostridium perfringens and Staphylococcus aureus for concurrent diagnosis and therapeutic applications","volume":"113","author":"Uppalapati","year":"2012","journal-title":"J. Appl. Microbiol."},{"issue":"42","key":"10.1016\/j.intimp.2020.106617_b0140","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1016\/j.vaccine.2010.07.061","article-title":"Immunogenic properties of chimeric protein from espA, eae and tir genes of Escherichia coli O157: H7","volume":"28","author":"Amani","year":"2010","journal-title":"Vaccine."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2020.106617_b0145","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.vetimm.2012.09.019","article-title":"Mucosal priming of the murine immune system against enterohemorrhagic Escherichia coli O157: H7 using Lactococcus lactis expressing the type III secretion system protein EspB","volume":"152","author":"Ahmed","year":"2013","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"25","key":"10.1016\/j.intimp.2020.106617_b0150","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1016\/j.vaccine.2014.03.021","article-title":"Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein","volume":"32","author":"Uppalapati","year":"2014","journal-title":"Vaccine."},{"issue":"6","key":"10.1016\/j.intimp.2020.106617_b0155","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1128\/jcm.22.6.897-902.1985","article-title":"Quantitation of HeLa cell monolayer invasion by Shigella and Salmonella species","volume":"22","author":"Niesel","year":"1985","journal-title":"J. Clin. Microbiol."},{"issue":"2008","key":"10.1016\/j.intimp.2020.106617_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2009\/647862","article-title":"Lactobacillusrhamnosus GG suppresses meningiticE. coli K1 penetration across human intestinal epithelial cells in vitro and protects neonatal rats against experimental hematogenous meningitis","author":"Huang","year":"2009","journal-title":"Int. J. Microbiol."},{"key":"10.1016\/j.intimp.2020.106617_b0165","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.vaccine.2004.05.026","article-title":"coli CFA\/I fimbrial protein protects Caco-2 cells from bacterial attachment","author":"Lee","year":"2004","journal-title":"Vaccine."},{"issue":"8","key":"10.1016\/j.intimp.2020.106617_b0170","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1128\/iai.58.8.2438-2445.1990","article-title":"Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157: H7","volume":"58","author":"Wadolkowski","year":"1990","journal-title":"Infect. Immun."},{"issue":"44","key":"10.1016\/j.intimp.2020.106617_b0175","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1016\/j.vaccine.2016.08.034","article-title":"Development of recombinant vaccine candidate molecule against Shigella infection","volume":"34","author":"Chitradevi","year":"2016","journal-title":"Vaccine."},{"issue":"3","key":"10.1016\/j.intimp.2020.106617_b0180","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.diagmicrobio.2015.03.015","article-title":"Prevalence of E. coli O157: H7 in water sources: an overview on associated diseases, outbreaks and detection methods","volume":"82","author":"Saxena","year":"2015","journal-title":"Diagno Microbiol. Infect Dis."},{"issue":"6","key":"10.1016\/j.intimp.2020.106617_b0185","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jiph.2017.01.003","article-title":"An outbreak of shigellosis in a Children Welfare Institute caused by a multiple-antibiotic-resistant strain of Shigella flexneri 2a","volume":"10","author":"Shen","year":"2017","journal-title":"J. Infect Public Health."},{"issue":"1","key":"10.1016\/j.intimp.2020.106617_b0190","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/jam.13124","article-title":"Treatment of in vitro enterohemorrhagic Escherichia coli infection using phage and probiotics","volume":"121","author":"Dini","year":"2016","journal-title":"J. Appl. Microbiol."},{"issue":"4","key":"10.1016\/j.intimp.2020.106617_b0195","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.vaccine.2011.11.098","article-title":"Lactococcus lactis-based vaccines from laboratory bench to human use: an overview","volume":"30","author":"Bahey-El-Din","year":"2012","journal-title":"Vaccine."},{"key":"10.1016\/j.intimp.2020.106617_b0200","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fmicb.2017.00417","article-title":"Oral immunization with recombinant Lactobacillus acidophilus expressing espA-Tir-M confers protection against enterohemorrhagic Escherichia coli O157: H7 challenge in mice","volume":"8","author":"Lin","year":"2017","journal-title":"Front. Microbiol."},{"issue":"8","key":"10.1016\/j.intimp.2020.106617_b0205","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1348-0421.2012.00477.x","article-title":"Oral immunization with attenuated Salmonella vaccine expressing Escherichia coli O157: H7 intimin gamma triggers both systemic and mucosal humoral immunity in mice","volume":"56","author":"Oliveira","year":"2012","journal-title":"Microbiol. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2020.106617_b0210","article-title":"Expression of EspA in Lactococcus lactis NZ9000 and the detection of its immune effect in vivo and vitro","volume":"32","author":"Luan","year":"2010","journal-title":"ImmunopharmacolImmunotoxicol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106617_b0215","doi-asserted-by":"crossref","DOI":"10.1111\/jam.13353","article-title":"Immunization with r-Lactococcus lactis expressing outer membrane protein A of Shigella dysenteriae type- 1: evaluation of oral and intranasal route of administration","volume":"122","author":"Yagnik","year":"2017","journal-title":"J. Appl. Microbiol."},{"issue":"23","key":"10.1016\/j.intimp.2020.106617_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2019.04.053","article-title":"Oral immunization with LacVax\u00ae OmpA induces protective immune response against Shigella flexneri 2a ATCC 12022 in a murine model","volume":"37","author":"Yagnik","year":"2019","journal-title":"Vaccine."},{"key":"10.1016\/j.intimp.2020.106617_b0225","doi-asserted-by":"crossref","unstructured":"Wells, Mucosal vaccination and therapy with genetically modified lactic acid bacteria. Annu Rev Food Sci Technol. 2 (2011) 423-45. https:\/\/doi.org\/10.1146\/annurev-food-022510-133640.","DOI":"10.1146\/annurev-food-022510-133640"},{"issue":"1","key":"10.1016\/j.intimp.2020.106617_b0230","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00388.x","article-title":"CD4+ T cell memory: generation and multi-faceted roles for CD4+ T cells in protective immunity to influenza","volume":"211","author":"Swain","year":"2006","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2020.106617_b0235","doi-asserted-by":"crossref","first-page":"91632","DOI":"10.1371\/journal.pone.0091632","article-title":"Immunization with H7-HCP-tir-intimin significantly reduces colonization and shedding of Escherichia coli O157: H7 in goats","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.intimp.2020.106617_b0240","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1073\/pnas.0610833104","article-title":"O-Specific polysaccharide conjugate vaccine-induced IgG antibodies prevent invasion of Shigella into Caco-2 cells and may be curative","volume":"104","author":"Chowers","year":"2007","journal-title":"PNAS"},{"issue":"24","key":"10.1016\/j.intimp.2020.106617_b0245","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1016\/j.vaccine.2013.04.012","article-title":"Parenteral immunization with IpaB\/IpaD protects mice against lethal pulmonary infection by Shigella","volume":"31","author":"Martinez-Becerra","year":"2013","journal-title":"Vaccine."},{"issue":"28","key":"10.1016\/j.intimp.2020.106617_b0250","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1016\/j.vaccine.2013.04.045","article-title":"Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD","volume":"31","author":"Heine","year":"2013","journal-title":"Vaccine."},{"issue":"4","key":"10.1016\/j.intimp.2020.106617_b0255","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1128\/CVI.00661-14","article-title":"Shigella outer membrane protein PSSP-1 is broadly protective against Shigella infection","volume":"22","author":"Kim","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.intimp.2020.106617_b0260","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.3389\/fmicb.2018.02609","article-title":"Cross-Protective Shigella Whole-Cell Vaccine With a Truncated O-Polysaccharide Chain","volume":"9","author":"Kim","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2020.106617_b0265","doi-asserted-by":"crossref","unstructured":"G.F. Asensi, N.F. de Sales, F.F. Dutra, D.F. Feijo, M.T. Bozza, R.G. Ulrich, A. Miyoshi, K. De Morais, V.A. de Carvalho Azevedo, J.T. Silva, Y. Le Loir, Oral immunization with Lactococcus lactis secreting attenuated recombinant staphylococcal enterotoxin B induces a protective immune response in a murine model. Microb Cell Fact. 12(1) (2013) 32.","DOI":"10.1186\/1475-2859-12-32"},{"issue":"4","key":"10.1016\/j.intimp.2020.106617_b0270","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1128\/IAI.66.4.1342-1348.1998","article-title":"An essential role for gamma interferon in innate resistance to Shigella flexneri infection","volume":"66","author":"Way","year":"1998","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.intimp.2020.106617_b0275","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.4049\/jimmunol.0901838","article-title":"Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits","volume":"183","author":"Boullier","year":"2009","journal-title":"J. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920304677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920304677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:16:20Z","timestamp":1761585380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920304677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":55,"alternative-id":["S1567576920304677"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106617","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterologous expression of Intimin and IpaB fusion protein in Lactococcus lactis and its mucosal delivery elicit protection against pathogenicity of Escherichia coli O157 and Shigella flexneri in a murine model","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106617","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106617"}}